Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM
- 13 November 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 25 (17), F21-F27
- https://doi.org/10.1097/qad.0b013e32834bac44
Abstract
Recent data indicate that seroprevalence of sexually transmitted hepatitis C virus (HCV) infection among MSM is stabilizing in Amsterdam. However, little is known about the incidence of HCV re-infection in MSM who have cleared their HCV infection. We, therefore, studied the incidence of re-infection in HIV-infected MSM who were HCV RNA-negative following HCV treatment of acute primary infection. Our study population comprised HIV-infected MSM at two large HIV outpatient clinics in Amsterdam, who were previously diagnosed with a sexually transmitted acute HCV infection and tested HCV RNA-negative at the end of treatment. We defined HCV re-infection as detectable HCV RNA in individuals with an undetectable HCV RNA at the end of treatment accompanied by a switch in HCV genotype or clade. Person–time methods were used to calculate the incidence of re-infection. Fifty-six persons who became HCV RNA-negative during primary acute HCV treatment were included. Five of the 56 cases relapsed and were not analysed. Eleven persons were re-infected. The incidence of HCV re-infection in this group was 15.2 per 100 person-years (95% confidence interval 8.0–26.5). The cumulative incidence was 33% within 2 years. An alarmingly high incidence of HCV re-infection was found in this group. This high re-infection rate indicates that current prevention measures should be discussed, frequent HCV RNA testing should be continued after successful treatment and, in case of possible relapse, clade typing should be performed to exclude re-infection.This publication has 33 references indexed in Scilit:
- Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis CThe Journal of Infectious Diseases, 2011
- Dynamic Coinfection with Multiple Viral Subtypes in Acute Hepatitis CThe Journal of Infectious Diseases, 2010
- IL28B SNP rs8099917 Is Strongly Associated with Pegylated Interferon-α and Ribavirin Therapy Treatment Failure in HCV/HIV-1 Coinfected PatientsPLOS ONE, 2010
- Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infectionHepatology, 2010
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature, 2009
- Diagnosis, management, and treatment of hepatitis C: An updateHepatology, 2008
- High incidence of hepatitis C virus reinfection in a cohort of injecting drug usersHepatology, 2008
- A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virusDrug and Alcohol Dependence, 2008
- Clustal W and Clustal X version 2.0Bioinformatics, 2007
- Use of Sequence Analysis of the NS5B Region for Routine Genotyping of Hepatitis C Virus with Reference to C/E1 and 5′ Untranslated Region SequencesJournal of Clinical Microbiology, 2007